Name: Wanbury Limited Financial Filings and Reports
Creator: FinancialReports
License: https://financialreports.eu/terms/

Filings indexed 916 across all filing types

Latest filing 2023-05-22 Regulatory Filings

Country IN India

Listing BSE.NS WANBURY

About Wanbury Limited

https://www.wanbury.com

Wanbury Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and finished formulations. The organization maintains a significant global presence, particularly as a leading producer of Metformin. Its product portfolio spans diverse therapeutic areas, including gynecology, orthopedics, hematinics, and anti-diabetics. The company operates manufacturing facilities compliant with international regulatory standards, including the USFDA. Wanbury focuses on providing medicinal solutions through integrated research and development capabilities and large-scale production infrastructure, serving both domestic and international markets with a range of specialty products.

Recent filings

Filing	Released	Lang
WANBURY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 ,inter alia, to consider and approve the Audited Financial Results & Statements .... Regulatory Filings	2023-05-22	English
Disclosure under SEBI Takeover Regulations Regulatory Filings	2023-05-11	English
Pursuant to Regulation 40(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the Compliance Certificate for the period from 1st .... Regulatory Filings	2023-04-21	English
Pursuant to the SEBI Circular No.: SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018, regarding Fund Raising by Issuance of Debt Securities by Large Entities; this is to confirm that .... Regulatory Filings	2023-04-20	English
Pursuant to the SEBI Circular No.: SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018, regarding Fund Raising by Issuance of Debt Securities by Large Entities; this is to confirm that .... Regulatory Filings	2023-04-20	English
Pursuant to Regulation 74 (5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, we are enclosing herewith Certificate dated 3rd April, 2023 .... Regulatory Filings	2023-04-05	English

Browse filings by year

17 years

	ID	Filing	Released	Lang
2023 15 filings
	46590982	WANBURY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 ,inter alia, to consider and approve the Audited Financial Results & Statements .... Regulatory Filings	2023-05-22	English
	42838351	Disclosure under SEBI Takeover Regulations Regulatory Filings	2023-05-11	English
	46591000	Pursuant to Regulation 40(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the Compliance Certificate for the period from 1st .... Regulatory Filings	2023-04-21	English
	46590993	Pursuant to the SEBI Circular No.: SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018, regarding Fund Raising by Issuance of Debt Securities by Large Entities; this is to confirm that .... Regulatory Filings	2023-04-20	English
	46590997	Pursuant to the SEBI Circular No.: SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018, regarding Fund Raising by Issuance of Debt Securities by Large Entities; this is to confirm that .... Regulatory Filings	2023-04-20	English
	46591004	Pursuant to Regulation 74 (5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, we are enclosing herewith Certificate dated 3rd April, 2023 .... Regulatory Filings	2023-04-05	English
	46591006	Pursuant to Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the Compliance Certificate for the year i.e. from .... Regulatory Filings	2023-04-05	English
	42847052	Certificate under SEBI (Depositories and Participants) Regulations, 2018 Regulatory Filings	2023-04-05	English
	46591002	Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, we wish to inform that the Trading Window for dealing in securities of Wanbury Limited (the "Company") shall remain .... Regulatory Filings	2023-03-30	English
	42844154	Trading Window Regulatory Filings	2023-03-30	English
	46591007	In terms of provisions of Regulation 30 read with Schedule III of the Listing Regulations, this is to inform you that Ms. Manisha Juvekar (DIN: 09053979) and Mr. Binod Chandra Maharana .... Regulatory Filings	2023-03-27	English
	42879163	Change in Management Regulatory Filings	2023-03-27	English
	42908684	Financial Result Updates Regulatory Filings	2023-02-14	English
	42908797	Outcome of Board Meeting Regulatory Filings	2023-02-14	English
	46591022	This is with reference to the above mentioned subject, we would like to inform you that the Board of Directors of the Company at its meeting held today, ie. 14th February, 2023 has considered .... Regulatory Filings	2023-02-14	English

Page 32 of 62

Prev … 30 31 32 33 34 … Next

Market data

Market data not available

Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products

2,202 peers

Company	Ticker	Country	Sector
13260917 Canada Inc. Biotech developing oral small molecules to restore muscle s…	MSCL	CA	Manufacturing
1608557 Ontario Inc. Biopharmaceutical company dedicated to R&D, discovery, and …	OTROQ	CA	Manufacturing
3B BlackBio Dx Limited Develops molecular diagnostic kits for oncology, infectious…	3BBLACKBIO	IN	Manufacturing
3D Medicines Inc. Commercial-stage biopharma specializing in next-generation …	1244	HK	Manufacturing
3SBio Inc. Biopharmaceutical enterprise specializing in R&D, productio…	1530	KY	Manufacturing
4BASEBIO PLC Manufactures GMP-grade synthetic DNA for next-generation th…	4BB	GB	Manufacturing
4D Molecular Therapeutics, Inc. Develops genetic medicines using AAV vectors for ophthalmol…	FDMT	US	Manufacturing
4Front Ventures Corp. Vertically integrated cannabis operator managing cultivatio…	FFNT	CA	Manufacturing
4SC AG Biopharmaceutical company with no products under developmen…	VSC	DE	Manufacturing
60 DEGREES PHARMACEUTICALS, INC. Develops and commercializes medicines for infectious diseas…	SXTP	US	Manufacturing

Page 1 of 221

1 2 3 … Next

Wanbury Limited via the API

Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.

Get API access Read API reference

Base URLapi.financialreports.eu

Auth headerx-api-key

Company ID60248

TickerWANBURY

ISININE107F01022

Endpoints

most-used routes for this company

GET	/api/companies/60248/	Company identity, sector, listing, identifiers
GET	/api/filings/?company=60248	Paginated list of all filings (filterable by type, date, language)
GET	/api/filings/{id}/	Single filing — metadata, document URL, processing status
GET	/api/filings/{id}/markdown/	Filing content as Markdown (PDF → text/tables/figures)
GET	/api/isins/?company=60248	All ISINs registered to this company
GET	/api/filing-types/	Reference: every filing-type code + category

Full reference: API reference · OpenAPI schema

cURL

latest filings for Wanbury Limited

$ curl https://api.financialreports.eu/api/filings/?company=60248 \
    -H "x-api-key: $FR_API_KEY" \
    -H "Accept: application/json"

Python

requests

import requests

r = requests.get(
    "https://api.financialreports.eu/api/filings/",
    params={"company": 60248},
    headers={"x-api-key": API_KEY},
)
filings = r.json()["results"]

MCP server

Claude · Claude Code · ChatGPT

Claude setup ChatGPT setup Claude Code setup

// MCP server URL
https://mcp.financialfilings.com/mcp

// Once connected, the LLM can query this company directly:
"Pull the latest 5 filings for Wanbury Limited (id: 60248)"

Wanbury Limited — Investor Relations & Filings